The neurodegenerative disorder drug developer has emerged from stealth to commercialise Howard Hughes Medical Institute research.

Eli Lilly, Novartis Venture Fund and AbbVie Ventures are among the contributors to a series A round disclosed as the neurodegenerative disorder drug developer emerged from stealth.

The Sberbank-backed online lender has announced the appointment of a new chief executive alongside its latest round.

Hanwha Investment & Securities led a series B round for the payment software producer that also featured SoftBank Ventures Asia and SK Networks.

The ride hailing service has sold its Uber Elevate subsidiary to urban aircraft developer and portfolio company Joby alongside a new $75m investment.

Corporate venturing unit Coinbase Ventures backed the Latin American crypto trading platform developer, which counts Monex and Ripple as earlier investors.

This latest funding round for the CAA-backed meditation app developer doubled its valuation to $2bn and brought its total funding to $217m.

SoftBank Opportunity Fund has backed a debt and equity round that reportedly valued the hair appointment management platform at $250m.

The mitochondrial disease therapy developer's latest round was co-led by Novo Ventures and backed by returning investor Lundbeckfonden Ventures.

Koch Industries took part in a series B round for the identity management platform developer that increased its total funding to $105m since its launch earlier this year.